TAK-931 is a CDC7-selective kinase inhibitor that has anti-proliferative activity across various cancer cell lines and causes tumor growth inhibition in multiple cancer xenograft models, including human colorectal, lung, ovarian, and pancreatic cancer37. Here, CDC7 is linked to cancer.